1. Home
  2. COEP vs GNS Comparison

COEP vs GNS Comparison

Compare COEP & GNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COEP
  • GNS
  • Stock Information
  • Founded
  • COEP 2017
  • GNS 2002
  • Country
  • COEP United States
  • GNS Singapore
  • Employees
  • COEP N/A
  • GNS N/A
  • Industry
  • COEP Biotechnology: Biological Products (No Diagnostic Substances)
  • GNS Other Consumer Services
  • Sector
  • COEP Health Care
  • GNS Real Estate
  • Exchange
  • COEP Nasdaq
  • GNS Nasdaq
  • Market Cap
  • COEP 86.0M
  • GNS 81.8M
  • IPO Year
  • COEP N/A
  • GNS 2022
  • Fundamental
  • Price
  • COEP $15.29
  • GNS $0.89
  • Analyst Decision
  • COEP
  • GNS
  • Analyst Count
  • COEP 0
  • GNS 0
  • Target Price
  • COEP N/A
  • GNS N/A
  • AVG Volume (30 Days)
  • COEP 66.5K
  • GNS 1.8M
  • Earning Date
  • COEP 11-12-2025
  • GNS 09-23-2025
  • Dividend Yield
  • COEP N/A
  • GNS N/A
  • EPS Growth
  • COEP N/A
  • GNS N/A
  • EPS
  • COEP N/A
  • GNS N/A
  • Revenue
  • COEP $263,555.00
  • GNS $5,749,894.00
  • Revenue This Year
  • COEP N/A
  • GNS $62.23
  • Revenue Next Year
  • COEP N/A
  • GNS $69.63
  • P/E Ratio
  • COEP N/A
  • GNS N/A
  • Revenue Growth
  • COEP N/A
  • GNS N/A
  • 52 Week Low
  • COEP $2.31
  • GNS $0.21
  • 52 Week High
  • COEP $19.19
  • GNS $1.92
  • Technical
  • Relative Strength Index (RSI)
  • COEP 49.85
  • GNS 45.46
  • Support Level
  • COEP $14.90
  • GNS $0.85
  • Resistance Level
  • COEP $16.17
  • GNS $0.93
  • Average True Range (ATR)
  • COEP 1.17
  • GNS 0.08
  • MACD
  • COEP -0.30
  • GNS -0.01
  • Stochastic Oscillator
  • COEP 11.94
  • GNS 14.69

About COEP Coeptis Therapeutics Holdings Inc.

Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.

About GNS Genius Group Limited

Genius Group Ltd is an Edtech and education company that provides entrepreneur education system business development tools and management consultancy services to entrepreneurs and entrepreneur resorts. The company's business consists of two reportable business segments: Education, which involves entrepreneur education, management consultancy, and business development tools; and Campus, consisting of resorts, retreats, and co-working cafes for entrepreneurs. It derives the majority of its revenue from the Education segment. Geographically, it operates in Europe/Middle East/Africa, Asia/Pacific, and North America/South America. The company derives maximum revenue from Europe/Middle East/Africa.

Share on Social Networks: